2015-2019 Global Campylobacter Diagnostic Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers - US, Europe (France, Germany, Italy, Spain, UK), Japan
The report presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Campylobacter definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health LabsFor each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Campylobacter tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Contains 230 pages and 14 tables
I. INTRODUCTION
II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatch/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatch/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
LIST OF TABLES
Table 1. Major Companies Developing or Marketing AIDS Tests
Table 2. Spain: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
Table 3. Spain: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4. Spain: Western Blot/Other Confirmatory Tests Volume and Sales Forecast by Market Segment
Table 5. Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6. Spain: AIDS Diagnostics Market by Major Supplier
Table 7. Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Table 1. Major Companies Developing or Marketing AIDS Tests
Table 2. Spain: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
Table 3. Spain: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4. Spain: Western Blot/Other Confirmatory Tests Volume and Sales Forecast by Market Segment
Table 5. Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6. Spain: AIDS Diagnostics Market by Major Supplier
Table 7. Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
